Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease: the GOLD science committee report 2019

D Singh, A Agusti, A Anzueto, PJ Barnes… - European …, 2019 - Eur Respiratory Soc
Precision medicine is a patient-specific approach that integrates all relevant clinical, genetic
and biological information in order to optimise the therapeutic benefit relative to the …

[HTML][HTML] Blood eosinophils and chronic obstructive pulmonary disease: a global initiative for chronic obstructive lung disease science committee 2022 review

D Singh, A Agusti, FJ Martinez, A Papi… - American journal of …, 2022 - atsjournals.org
The Global Initiative for Chronic Obstructive Lung Disease (GOLD) published its first report
for the diagnosis and management of chronic obstructive pulmonary disease (COPD) in …

[HTML][HTML] COVID-19 and COPD: a narrative review of the basic science and clinical outcomes

A Higham, A Mathioudakis, J Vestbo… - European respiratory …, 2020 - Eur Respiratory Soc
The 2019 coronavirus disease (COVID-19) pandemic is caused by severe acute respiratory
syndrome-coronavirus-2 (SARS-CoV-2). Clinical outcomes, including mortality, are worse in …

Blood eosinophils and treatment response with triple and dual combination therapy in chronic obstructive pulmonary disease: analysis of the IMPACT trial

S Pascoe, N Barnes, G Brusselle… - The Lancet …, 2019 - thelancet.com
Background Previous studies have highlighted a relationship between reduction in rate of
exacerbations with therapies containing inhaled corticosteroids (ICS) and baseline blood …

Chronic obstructive pulmonary disease biomarkers and their interpretation

RA Stockley, DMG Halpin, BR Celli… - American journal of …, 2019 - atsjournals.org
The pathology and impact of chronic obstructive pulmonary disease (COPD) results from an
abnormal inflammatory process resulting in tissue damage with ineffective repair in …

[HTML][HTML] Blood and sputum eosinophils in COPD; relationship with bacterial load

U Kolsum, GC Donaldson, R Singh, BL Barker… - Respiratory …, 2017 - Springer
Background Sputum and blood eosinophil counts predict corticosteroid effects in COPD
patients. Bacterial infection causes increased airway neutrophilic inflammation. The …

Fatigue in COPD: an important yet ignored symptom

MA Spruit, JH Vercoulen, MAG Sprangers… - The lancet respiratory …, 2017 - thelancet.com
Breathlessness, cough, and sputum production are cardinal symptoms of patients with
chronic obstructive pulmonary disease (COPD). These respiratory symptoms are routinely …

Pulmonary inflammation in patients with chronic obstructive pulmonary disease with higher blood eosinophil counts

U Kolsum, G Damera, TH Pham… - Journal of Allergy and …, 2017 - jacionline.org
This work was supported by grant numbers R01ES023349, P30ES010126, and US EPA CR
83578501. AJB is supported by grant number 2T32GM086330. CGD is supported by grant …

Pharmacological treatment of stable chronic obstructive pulmonary disease

D Singh - Respirology, 2021 - Wiley Online Library
Pharmacological treatment for chronic obstructive pulmonary disease (COPD) aims to
alleviate symptoms and reduce the future risk of events such as exacerbations, disease …

The pharmacological management of asthma-chronic obstructive pulmonary disease overlap syndrome (ACOS)

TE Albertson, JA Chenoweth, SJ Pearson… - Expert opinion on …, 2020 - Taylor & Francis
Introduction: Asthma-chronic obstructive pulmonary disease overlap syndrome (ACOS) is a
disease phenotype that shares T helper lymphocyte cell Th1/neutrophilic/non-Type-2 …